# Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olaparib-plus-bevacizumab-first-line-maintenance-in-ovarian-cancer-final-overall/

## Facts

| Field | Value |
| --- | --- |
| Author Names | I. Ray-Coquard,Alexandra Léary,Sandro Pignata,Claire Cropet,Antonio González-Martı́n,Christian Marth,Shoji Nagao,Ignace Vergote,Nicoletta Colombo,Johanna Mäenpää,Frédèric Selle,Jalid Sehouli,Domenica Lorusso,Eva María Guerra Alia,Gerhard Bogner,Hiroyuki Yoshida,C. Lefeuvre-Plesse,Paul Buderath,Anna Maria Mosconi,A. Lortholary,Alexander Burges,J. Medioni,Ayşe Balat,Manuel Rodrigues,Tjoung‐Won Park‐Simon,Coraline Dubot,Dominik Denschlag,Benoît You,Éric Pujade-Lauraine,Philipp Harter |
| Citations | 350 |
| DOI | 10.1016/j.annonc.2023.05.005 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753423006865/pdf |
| OpenAlex ID | https://openalex.org/W4377115689 |
| PMID | 37211045 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Gerhard Bogner](https://scholariq.org/researchers/gerhard-bogner/)
- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Nicoletta Colombo](https://scholariq.org/researchers/nicoletta-colombo/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.